Daily Archives: January 29, 2013

Patients story of complete clearance of his Psoriasis

By: Skincentre0com0au

More:
Patients story of complete clearance of his Psoriasis - Video

UVB Psoriasis unit. 2 bulbs unit
UVB LAMP for treating Psoriasis, Vitiligo, Exzema. LCD timer with voice prompt function alarm function countdown Phillips 9W narrow band lamp

By: usewsmile

See the original post here:
UVB Psoriasis unit. 2 bulbs unit - Video

OMG! Psoriasis Treatment - Psoriasis Cure (THIS WORKS)

By: IPromoteMedia

See original here:
OMG! Psoriasis Treatment - Psoriasis Cure (THIS WORKS) - Video

We know the Kardashian sister's are close but we weren't ready for this video showing Kourtney Kardashian squirting her breast milk directly onto Kim Kardashian's leg.

Kourtney was actually trying to help heal Kim's psoriasis rash as Kim said putting breast milk on the area had been helping.

But even Kim looked a bit freaked out when Kourt decided to squirt some milk on her straight from the boob.

Breat milk actually has some known soothing qualities so maybe the sister's have found a new cure.

We'll have our eye on Kim's legs from now on to see if the boob milk did the job!

Check out the clip below...

Would you give breast milk a try for your rash? Leave a comment below to be in with a chance of winning a 100 goodie bag

YAY OR NAY: KIM KARDASHIAN'S FEATHER DRESS

WATCH: NEW DIET COKE HUNK REVEALED

TOP 10 FAIRYTALE REMAKES

The rest is here:
WATCH: Kim Kardashian getting squirted with breast milk to heal psoriasis

Today, a new product called DermaZor cream was released to the public. This all-natural treatment dramatically improves the skin of those who suffer from psoriasis.

Tel Aviv (PRWEB) January 28, 2013

DermaZor was developed over a period of 6 1/2 years and contains a unique formula consisting of natural medical ingredients including organic acid, zinc, flower extracts and organic oils. During the development process, tests were conducted in psoriasis clinics under the careful supervision and monitoring of a team of scientists, chemists and pharmacists. This team was headed by a globally renowned medical authority in the field of psoriasis.

In regards to the release of DermaZor, Iris Rave, VP of Marketing at Prestigio Co, stated "All tests show that DermaZor dramatically improves the condition of skin in just days! When used regularly, it can also prevent future outbursts of psoriasis. Our formula was developed with the best ingredients and optimal technology. All ingredients are of the finest quality and are carefully chosen from the most trustworthy suppliers worldwide."

DermaZor is also unique in that it can be used on any part of the body, even the most sensitive areas. It is also safe for ages 2 and up. The formulate is grease-free formula so it will never stain and it is completely free of any side effects. Iris Rave adds, "We are proud to offer the definitive answer for those looking for a way to control and relieve psoriasis."

Those looking for complementary samples of DermaZor can email info(at)dermazor(dot)com or call 1-888-284-9864 (US and Canada Toll Free) or +972-3-632-90-10 (Internationally).

About Prestigio:

Prestigio, a privately owned company based in Israel, was established with a mission:

finding a real, scientific and well-based solution for the treatment of psoriatic lesions that will heal the skin and enable patients to live a new, free, confident, peaceful and fulfilling life. Prestigio has established a state of the art technological system, based on the most innovative knowledge in the field of skin disease and psoriasis. The company employs only the best doctors, pharmacists and chemists, who are world-renowned in the fields of dermatology. All Prestigio products are manufactured in advanced laboratories according to strict international regulations, and under strict quality control, using only natural materials, with proven therapeutic efficacy. Visit http://www.dermazor.net for more information.

Iris Rave Prestigio +972-3-632-90-10 Email Information

Read this article:
Revolutionary DermaZor Cream Provides "New Life" for Psoriasis Patients

SINGAPORE, Jan. 28, 2013 /PRNewswire/ --

Psoriasis is a little-understood skin condition that carries a strong social stigma through its emotional impact on sufferers that can far outweigh the disease's physical impact. That is why proper support and guidance from healthcare providers is crucial in achieving optimal treatment adherence, one of the main challenges in psoriasis management.

(Logo: http://www.newscom.com/cgi-bin/prnh/20110606/460992 )

LEO Pharma, the global leader in dermatology care, announced the launch of the PsorCARE program in Asia, starting with Singapore, on 26 January 2013. The first-of-its-kind initiative in the region, PsorCARE, which stands for "Psoriasis Coach All-Round Education", will kick off on 26 January, 2013. Developed by LEO Pharma Asia and PsorAsia, PsorCARE's goal is to enhance the counseling skills of healthcare practitioners for optimal patient-healthcare provider relationship leading to better treatment outcomes for those who suffer from the skin condition Psoriasis.

"LEO Pharma is committed to bringing this program to Asia because we are aware of the challenges that patients with Psoriasis face in their everyday lives. We want patients with Psoriasis to know that trained support is available and that it is possible for them to live life as normally as possible. Our ultimate aim is to give these patients hope and help improve the quality of their lives," said Mr. Ng Choon-Peng, Chief Executive Officer of LEO Pharma Asia Pte Ltd.

Psoriasis - the disease

Psoriasis is a chronic non-contagious inflammatory skin condition that affects approximately 40,000 Singaporeans[1], and up to three in every hundred people globally[2]. It is also one of the top ten most common skin diseases in Singapore[3], but is little understood amongst the general public, earning it a social stigma for its highly visible effects on human skin, such as thick, silvery scales and pink raised skin. Hence, Psoriasis also exerts a psychological toll on patients, with a 44 percent increased risk of suicide, a 39 percent increased risk of depression, and a 31 percent increased risk of anxiety. Patients with severe psoriasis have a 72 percent increased risk of depression[4].

The need for the PsorCARE program

Many patients require a deeper and better understanding of the disease and the treatment options, which can be achieved with improved access to information through healthcare professionals. With professional counseling readily available, patients have the necessary support to better able to manage both the physical and psychological toll from living with Psoriasis.

For patients who require long-term therapy for Psoriasis, treatment adherence - whether it be medicinal, behavioral, lifestyle or a combination of treatments - is essential for achieving optimal outcomes. Extensive market research has identified that adherence is founded on good communication and a positive relationship between the patient and healthcare practitioners. This applies in particular to nurses who are in regular contact with patients[5].

Visit link:
PsorCARE Program by LEO Pharma Asia Focuses on Treatment Adherence to Improve Psoriasis Treatment Outcomes

The skin condition psoriasis may increase the risk of stroke and atrial fibrillation, a condition in which the heart beats irregularly, a new Danish study says.

Don't miss these Health stories

The early flu season continues to worsen across the United States, the Centers for Disease Control and Prevention says. Flu has killed 29 children this year so far.

In some cases, patients with psoriasis had nearly 3 times the risk of experiencing these conditions compared with people without psoriasis. The risk was greater in patients with severe psoriasis.

The findings add to a growing body of research linking psoriasis with heart and blood vessel problems, including an increased risk of heart attack and death from cardiovascular disease.

"In recent years, psoriasis has certainly taken the step from a disease affecting appearance to a systemic disease and cardiovascular risk factor," said study researcher Dr. Ole Ahlehoff, a cardiologist at Copenhagen University Hospital Gentofte.

Patients with psoriasis should be monitored for indicators of cardiovascular disease, including heart arrhythmias, Ahleoffsaid.

And these patients may be candidates for interventions that will reduce cardiovascular disease risk, including lifestyle modifications, such as quitting smoking and getting more exercise, and in some cases, medications, Ahlehoff said.

MyHealthNewsDaily

Future studies should investigate whether treating psoriasis reduces patients' cardiovascular disease risk, he said.

View original post here:
Psoriasis may increase stroke risk, study says